Lab21 sells South Carolina laboratory operations
Will continue to focus on diagnostic content opportunities within the US market
Lab21, a UK specialist in personalised medicine and clinical diagnostics, has sold its loss-making laboratory operations in the US for an undisclosed sum.
The Cambridge-based company has sold the facility to Reedy Acquisitions Corp, a group comprising local management and investors based in South Carolina.
Susan Lowther, CFO of Lab21, said: ‘After three years of developing the clinical service business in South Carolina, the Group has taken the decision to sell the laboratory operations in Greenville and Columbia.
‘This sale does not impact our core strategy to focus on personalised medicine and Lab21 will continue to focus on diagnostic content strategy opportunities within the US market.’